Net Loss of Transgene Biotek reported to Rs 0.37 crore in the quarter ended December 2025 as against net loss of Rs 0.09 crore during the previous quarter ended December 2024. Sales declined 37.50% to Rs 0.05 crore in the quarter ended December 2025 as against Rs 0.08 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales0.050.08 -38 OPM %-100.00-112.50 - PBDT-0.32-0.07 -357 PBT-0.37-0.09 -311 NP-0.37-0.09 -311 Powered by Capital Market - Live News

Transgene Biotek will hold a meeting of the Board of Directors of the Company on 13 February 2026.Powered by Capital Market - Live News

Transgene Biotek announced that the 35th Annual General Meeting(AGM) of the company will be held on 30 December 2025.Powered by Capital Market - Live News

Net Loss of Transgene Biotek reported to Rs 0.39 crore in the quarter ended September 2025 as against net loss of Rs 0.07 crore during the previous quarter ended September 2024. Sales declined 16.67% to Rs 0.05 crore in the quarter ended September 2025 as against Rs 0.06 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales0.050.06 -17 OPM %-140.00-116.67 - PBDT-0.34-0.05 -580 PBT-0.39-0.07 -457 NP-0.39-0.07 -457 Powered by Capital Market - Live News

Transgene Biotek will hold a meeting of the Board of Directors of the Company on 14 November 2025.Powered by Capital Market - Live News